{"cik":1468639,"entityName":"VICAPSYS LIFE SCIENCES, INC.","facts":{"dei":{"EntityCommonStockSharesOutstanding":{"label":"Entity Common Stock, Shares Outstanding","description":"Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.","units":{"shares":[{"end":"2020-05-15","val":17483283,"accn":"0001493152-20-009028","fy":2020,"fp":"Q1","form":"10-Q","filed":"2020-05-15","frame":"CY2020Q1I"}]}}},"us-gaap":{"AccountsPayableCurrent":{"label":"Accounts Payable, Current","description":"Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).","units":{"USD":[{"end":"2019-12-31","val":396482,"accn":"0001493152-20-009028","fy":2020,"fp":"Q1","form":"10-Q","filed":"2020-05-15","frame":"CY2019Q4I"},{"end":"2020-03-31","val":501729,"accn":"0001493152-20-009028","fy":2020,"fp":"Q1","form":"10-Q","filed":"2020-05-15","frame":"CY2020Q1I"}]}},"AccruedSalariesCurrent":{"label":"Accrued Salaries, Current","description":"Carrying value as of the balance sheet date of the obligations incurred through that date and payable for employees' services provided. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).","units":{"USD":[{"end":"2020-03-31","val":16408,"accn":"0001493152-20-009028","fy":2020,"fp":"Q1","form":"10-Q","filed":"2020-05-15","frame":"CY2020Q1I"}]}},"AdditionalPaidInCapital":{"label":"Additional Paid in Capital","description":"Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.","units":{"USD":[{"end":"2019-12-31","val":13403293,"accn":"0001493152-20-009028","fy":2020,"fp":"Q1","form":"10-Q","filed":"2020-05-15","frame":"CY2019Q4I"},{"end":"2020-03-31","val":13408701,"accn":"0001493152-20-009028","fy":2020,"fp":"Q1","form":"10-Q","filed":"2020-05-15","frame":"CY2020Q1I"}]}},"AdjustmentForAmortization":{"label":"Amortization","description":"The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives.","units":{"USD":[{"start":"2019-01-01","end":"2019-03-31","val":7821,"accn":"0001493152-20-009028","fy":2020,"fp":"Q1","form":"10-Q","filed":"2020-05-15","frame":"CY2019Q1"},{"start":"2020-01-01","end":"2020-03-31","val":7863,"accn":"0001493152-20-009028","fy":2020,"fp":"Q1","form":"10-Q","filed":"2020-05-15","frame":"CY2020Q1"}]}},"AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet":{"label":"Adjustment to Additional Paid in Capital, Income Tax Effect from Share-based Compensation, Net","description":"Amount of increase (decrease) in additional paid in capital (APIC) resulting from a tax benefit (deficiency) associated with an share-based compensation plan other than an employee stock ownership plan (ESOP).","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":5408,"accn":"0001493152-20-009028","fy":2020,"fp":"Q1","form":"10-Q","filed":"2020-05-15","frame":"CY2020Q1"}]}},"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount":{"label":"Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount","description":"Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.","units":{"shares":[{"start":"2019-01-01","end":"2019-03-31","val":17672656,"accn":"0001493152-20-009028","fy":2020,"fp":"Q1","form":"10-Q","filed":"2020-05-15","frame":"CY2019Q1"},{"start":"2020-01-01","end":"2020-03-31","val":17688006,"accn":"0001493152-20-009028","fy":2020,"fp":"Q1","form":"10-Q","filed":"2020-05-15","frame":"CY2020Q1"}]}},"Assets":{"label":"Assets","description":"Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.","units":{"USD":[{"end":"2019-12-31","val":698439,"accn":"0001493152-20-009028","fy":2020,"fp":"Q1","form":"10-Q","filed":"2020-05-15","frame":"CY2019Q4I"},{"end":"2020-03-31","val":461043,"accn":"0001493152-20-009028","fy":2020,"fp":"Q1","form":"10-Q","filed":"2020-05-15","frame":"CY2020Q1I"}]}},"AssetsCurrent":{"label":"Assets, Current","description":"Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.","units":{"USD":[{"end":"2019-12-31","val":264166,"accn":"0001493152-20-009028","fy":2020,"fp":"Q1","form":"10-Q","filed":"2020-05-15","frame":"CY2019Q4I"},{"end":"2020-03-31","val":30948,"accn":"0001493152-20-009028","fy":2020,"fp":"Q1","form":"10-Q","filed":"2020-05-15","frame":"CY2020Q1I"}]}},"CashAndCashEquivalentsAtCarryingValue":{"label":"Cash and Cash Equivalents, at Carrying Value","description":"Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.","units":{"USD":[{"end":"2019-12-31","val":264166,"accn":"0001493152-20-009028","fy":2020,"fp":"Q1","form":"10-Q","filed":"2020-05-15","frame":"CY2019Q4I"},{"end":"2020-03-31","val":30948,"accn":"0001493152-20-009028","fy":2020,"fp":"Q1","form":"10-Q","filed":"2020-05-15","frame":"CY2020Q1I"}]}},"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations":{"label":"Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations","description":"Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.","units":{"USD":[{"end":"2018-12-31","val":86330,"accn":"0001493152-20-009028","fy":2020,"fp":"Q1","form":"10-Q","filed":"2020-05-15","frame":"CY2018Q4I"},{"end":"2019-03-31","val":3092,"accn":"0001493152-20-009028","fy":2020,"fp":"Q1","form":"10-Q","filed":"2020-05-15","frame":"CY2019Q1I"},{"end":"2019-12-31","val":264166,"accn":"0001493152-20-009028","fy":2020,"fp":"Q1","form":"10-Q","filed":"2020-05-15","frame":"CY2019Q4I"},{"end":"2020-03-31","val":30948,"accn":"0001493152-20-009028","fy":2020,"fp":"Q1","form":"10-Q","filed":"2020-05-15","frame":"CY2020Q1I"}]}},"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect":{"label":"Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect","description":"Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.","units":{"USD":[{"start":"2019-01-01","end":"2019-03-31","val":-83238,"accn":"0001493152-20-009028","fy":2020,"fp":"Q1","form":"10-Q","filed":"2020-05-15","frame":"CY2019Q1"},{"start":"2020-01-01","end":"2020-03-31","val":-233218,"accn":"0001493152-20-009028","fy":2020,"fp":"Q1","form":"10-Q","filed":"2020-05-15","frame":"CY2020Q1"}]}},"CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations":{"label":"Cash Provided by (Used in) Financing Activities, Discontinued Operations","description":"Amount of cash inflow (outflow) of financing activities of discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.","units":{"USD":[{"start":"2019-01-01","end":"2019-03-31","val":104500,"accn":"0001493152-20-009028","fy":2020,"fp":"Q1","form":"10-Q","filed":"2020-05-15","frame":"CY2019Q1"}]}},"CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations":{"label":"Cash Provided by (Used in) Operating Activities, Discontinued Operations","description":"Amount of cash inflow (outflow) of operating activities of discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.","units":{"USD":[{"start":"2019-01-01","end":"2019-03-31","val":-45380,"accn":"0001493152-20-009028","fy":2020,"fp":"Q1","form":"10-Q","filed":"2020-05-15","frame":"CY2019Q1"}]}},"CommonStockParOrStatedValuePerShare":{"label":"Common Stock, Par or Stated Value Per Share","description":"Face amount or stated value per share of common stock.","units":{"USD":[{"end":"2017-09-13","val":0.001,"accn":"0001493152-20-009028","fy":2020,"fp":"Q1","form":"10-Q","filed":"2020-05-15","frame":"CY2017Q3I"},{"end":"2019-12-31","val":0.001,"accn":"0001493152-20-009028","fy":2020,"fp":"Q1","form":"10-Q","filed":"2020-05-15","frame":"CY2019Q4I"},{"end":"2020-03-31","val":0.001,"accn":"0001493152-20-009028","fy":2020,"fp":"Q1","form":"10-Q","filed":"2020-05-15","frame":"CY2020Q1I"}]}},"CommonStockSharesAuthorized":{"label":"Common Stock, Shares Authorized","description":"The maximum number of common shares permitted to be issued by an entity's charter and bylaws.","units":{"shares":[{"end":"2017-09-13","val":300000000,"accn":"0001493152-20-009028","fy":2020,"fp":"Q1","form":"10-Q","filed":"2020-05-15","frame":"CY2017Q3I"},{"end":"2019-12-31","val":300000000,"accn":"0001493152-20-009028","fy":2020,"fp":"Q1","form":"10-Q","filed":"2020-05-15","frame":"CY2019Q4I"},{"end":"2020-03-31","val":300000000,"accn":"0001493152-20-009028","fy":2020,"fp":"Q1","form":"10-Q","filed":"2020-05-15","frame":"CY2020Q1I"}]}},"CommonStockSharesIssued":{"label":"Common Stock, Shares, Issued","description":"Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.","units":{"shares":[{"end":"2019-12-31","val":17483283,"accn":"0001493152-20-009028","fy":2020,"fp":"Q1","form":"10-Q","filed":"2020-05-15","frame":"CY2019Q4I"},{"end":"2020-03-31","val":17483283,"accn":"0001493152-20-009028","fy":2020,"fp":"Q1","form":"10-Q","filed":"2020-05-15","frame":"CY2020Q1I"}]}},"CommonStockSharesOutstanding":{"label":"Common Stock, Shares, Outstanding","description":"Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.","units":{"shares":[{"end":"2019-12-31","val":17483283,"accn":"0001493152-20-009028","fy":2020,"fp":"Q1","form":"10-Q","filed":"2020-05-15","frame":"CY2019Q4I"},{"end":"2020-03-31","val":17483283,"accn":"0001493152-20-009028","fy":2020,"fp":"Q1","form":"10-Q","filed":"2020-05-15","frame":"CY2020Q1I"}]}},"CommonStockValue":{"label":"Common Stock, Value, Issued","description":"Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.","units":{"USD":[{"end":"2019-12-31","val":17483,"accn":"0001493152-20-009028","fy":2020,"fp":"Q1","form":"10-Q","filed":"2020-05-15","frame":"CY2019Q4I"},{"end":"2020-03-31","val":17483,"accn":"0001493152-20-009028","fy":2020,"fp":"Q1","form":"10-Q","filed":"2020-05-15","frame":"CY2020Q1I"}]}},"DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicAndDilutedShare":{"label":"Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Basic and Diluted Share","description":"Per basic and diluted share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation, when the per share amount is the same.","units":{"USD":[{"start":"2019-01-01","end":"2019-03-31","val":-0.03,"accn":"0001493152-20-009028","fy":2020,"fp":"Q1","form":"10-Q","filed":"2020-05-15","frame":"CY2019Q1"}]}},"DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense":{"label":"Disposal Group, Including Discontinued Operation, General and Administrative Expense","description":"Amount of general and administrative expense attributable to disposal group, including, but not limited to, discontinued operation.","units":{"USD":[{"start":"2019-01-01","end":"2019-03-31","val":50282,"accn":"0001493152-20-009028","fy":2020,"fp":"Q1","form":"10-Q","filed":"2020-05-15","frame":"CY2019Q1"}]}},"DisposalGroupIncludingDiscontinuedOperationOperatingExpense":{"label":"Disposal Group, Including Discontinued Operation, Operating Expense","description":"Amount of operating expense attributable to disposal group, including, but not limited to, discontinued operation.","units":{"USD":[{"start":"2019-01-01","end":"2019-03-31","val":329062,"accn":"0001493152-20-009028","fy":2020,"fp":"Q1","form":"10-Q","filed":"2020-05-15","frame":"CY2019Q1"}]}},"DisposalGroupIncludingDiscontinuedOperationRevenue":{"label":"Disposal Group, Including Discontinued Operation, Revenue","description":"Amount of revenue attributable to disposal group, including, but not limited to, discontinued operation.","units":{"USD":[{"start":"2019-01-01","end":"2019-03-31","val":50000,"accn":"0001493152-20-009028","fy":2020,"fp":"Q1","form":"10-Q","filed":"2020-05-15","frame":"CY2019Q1"}]}},"EarningsPerShareBasicAndDiluted":{"label":"Earnings Per Share, Basic and Diluted","description":"The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.","units":{"USD":[{"start":"2019-01-01","end":"2019-03-31","val":-0.05,"accn":"0001493152-20-009028","fy":2020,"fp":"Q1","form":"10-Q","filed":"2020-05-15","frame":"CY2019Q1"},{"start":"2020-01-01","end":"2020-03-31","val":-0.02,"accn":"0001493152-20-009028","fy":2020,"fp":"Q1","form":"10-Q","filed":"2020-05-15","frame":"CY2020Q1"}]}},"EquityMethodInvestmentOwnershipPercentage":{"label":"Equity Method Investment, Ownership Percentage","description":"The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.","units":{"pure":[{"end":"2020-03-31","val":0.2,"accn":"0001493152-20-009028","fy":2020,"fp":"Q1","form":"10-Q","filed":"2020-05-15","frame":"CY2020Q1I"}]}},"FiniteLivedIntangibleAssetsAccumulatedAmortization":{"label":"Finite-Lived Intangible Assets, Accumulated Amortization","description":"Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.","units":{"USD":[{"end":"2019-12-31","val":58241,"accn":"0001493152-20-009028","fy":2020,"fp":"Q1","form":"10-Q","filed":"2020-05-15","frame":"CY2019Q4I"},{"end":"2020-03-31","val":66104,"accn":"0001493152-20-009028","fy":2020,"fp":"Q1","form":"10-Q","filed":"2020-05-15","frame":"CY2020Q1I"}]}},"FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive":{"label":"Finite-Lived Intangible Asset, Expected Amortization, after Year Five","description":"Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).","units":{"USD":[{"end":"2020-03-31","val":277777,"accn":"0001493152-20-009028","fy":2020,"fp":"Q1","form":"10-Q","filed":"2020-05-15","frame":"CY2020Q1I"}]}},"FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear":{"label":"Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year","description":"Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year.","units":{"USD":[{"end":"2020-03-31","val":23437,"accn":"0001493152-20-009028","fy":2020,"fp":"Q1","form":"10-Q","filed":"2020-05-15","frame":"CY2020Q1I"}]}},"FiniteLivedIntangibleAssetsAmortizationExpenseYearFive":{"label":"Finite-Lived Intangible Asset, Expected Amortization, Year Five","description":"Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).","units":{"USD":[{"end":"2020-03-31","val":31299,"accn":"0001493152-20-009028","fy":2020,"fp":"Q1","form":"10-Q","filed":"2020-05-15","frame":"CY2020Q1I"}]}},"FiniteLivedIntangibleAssetsAmortizationExpenseYearFour":{"label":"Finite-Lived Intangible Asset, Expected Amortization, Year Four","description":"Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).","units":{"USD":[{"end":"2020-03-31","val":31299,"accn":"0001493152-20-009028","fy":2020,"fp":"Q1","form":"10-Q","filed":"2020-05-15","frame":"CY2020Q1I"}]}},"FiniteLivedIntangibleAssetsAmortizationExpenseYearThree":{"label":"Finite-Lived Intangible Asset, Expected Amortization, Year Three","description":"Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).","units":{"USD":[{"end":"2020-03-31","val":31299,"accn":"0001493152-20-009028","fy":2020,"fp":"Q1","form":"10-Q","filed":"2020-05-15","frame":"CY2020Q1I"}]}},"FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo":{"label":"Finite-Lived Intangible Asset, Expected Amortization, Year Two","description":"Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).","units":{"USD":[{"end":"2020-03-31","val":31299,"accn":"0001493152-20-009028","fy":2020,"fp":"Q1","form":"10-Q","filed":"2020-05-15","frame":"CY2020Q1I"}]}},"FiniteLivedIntangibleAssetsNet":{"label":"Finite-Lived Intangible Assets, Net","description":"Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.","units":{"USD":[{"end":"2019-12-31","val":434273,"accn":"0001493152-20-009028","fy":2020,"fp":"Q1","form":"10-Q","filed":"2020-05-15","frame":"CY2019Q4I"},{"end":"2020-03-31","val":426410,"accn":"0001493152-20-009028","fy":2020,"fp":"Q1","form":"10-Q","filed":"2020-05-15","frame":"CY2020Q1I"}]}},"FiniteLivedPatentsGross":{"label":"Finite-Lived Patents, Gross","description":"Gross carrying amount before accumulated amortization as of the balance sheet date of the costs pertaining to the exclusive legal rights granted to the owner of the patent to exploit an invention or a process for a period of time specified by law. Such costs may have been expended to directly apply and receive patent rights, or to acquire such rights.","units":{"USD":[{"end":"2019-12-31","val":492514,"accn":"0001493152-20-009028","fy":2020,"fp":"Q1","form":"10-Q","filed":"2020-05-15","frame":"CY2019Q4I"},{"end":"2020-03-31","val":492514,"accn":"0001493152-20-009028","fy":2020,"fp":"Q1","form":"10-Q","filed":"2020-05-15","frame":"CY2020Q1I"}]}},"GeneralAndAdministrativeExpense":{"label":"General and Administrative Expense","description":"The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.","units":{"USD":[{"start":"2019-01-01","end":"2019-03-31","val":8720,"accn":"0001493152-20-009028","fy":2020,"fp":"Q1","form":"10-Q","filed":"2020-05-15","frame":"CY2019Q1"},{"start":"2020-01-01","end":"2020-03-31","val":14085,"accn":"0001493152-20-009028","fy":2020,"fp":"Q1","form":"10-Q","filed":"2020-05-15","frame":"CY2020Q1"}]}},"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest":{"label":"Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest","description":"Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.","units":{"USD":[{"start":"2019-01-01","end":"2019-03-31","val":-163595,"accn":"0001493152-20-009028","fy":2020,"fp":"Q1","form":"10-Q","filed":"2020-05-15","frame":"CY2019Q1"},{"start":"2020-01-01","end":"2020-03-31","val":-364459,"accn":"0001493152-20-009028","fy":2020,"fp":"Q1","form":"10-Q","filed":"2020-05-15","frame":"CY2020Q1"}]}},"IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest":{"label":"Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest","description":"Amount after tax of income (loss) from continuing operations including portion attributable to the noncontrolling interest.","units":{"USD":[{"start":"2019-01-01","end":"2019-03-31","val":-163595,"accn":"0001493152-20-009028","fy":2020,"fp":"Q1","form":"10-Q","filed":"2020-05-15","frame":"CY2019Q1"},{"start":"2020-01-01","end":"2020-03-31","val":-364459,"accn":"0001493152-20-009028","fy":2020,"fp":"Q1","form":"10-Q","filed":"2020-05-15","frame":"CY2020Q1"}]}},"IncomeLossFromContinuingOperationsPerBasicAndDilutedShare":{"label":"Income (Loss) from Continuing Operations, Per Basic and Diluted Share","description":"The amount of net income (loss) from continuing operations per each basic and diluted share of common stock or unit when the per share amount is the same for both basic and diluted shares.","units":{"USD":[{"start":"2019-01-01","end":"2019-03-31","val":-0.02,"accn":"0001493152-20-009028","fy":2020,"fp":"Q1","form":"10-Q","filed":"2020-05-15","frame":"CY2019Q1"},{"start":"2020-01-01","end":"2020-03-31","val":-0.02,"accn":"0001493152-20-009028","fy":2020,"fp":"Q1","form":"10-Q","filed":"2020-05-15","frame":"CY2020Q1"}]}},"IncomeLossFromDiscontinuedOperationsNetOfTax":{"label":"Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest","description":"Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.","units":{"USD":[{"start":"2019-01-01","end":"2019-03-31","val":-279062,"accn":"0001493152-20-009028","fy":2020,"fp":"Q1","form":"10-Q","filed":"2020-05-15","frame":"CY2019Q1"}]}},"IncreaseDecreaseInAccountsPayable":{"label":"Increase (Decrease) in Accounts Payable","description":"The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.","units":{"USD":[{"start":"2019-01-01","end":"2019-03-31","val":13416,"accn":"0001493152-20-009028","fy":2020,"fp":"Q1","form":"10-Q","filed":"2020-05-15","frame":"CY2019Q1"},{"start":"2020-01-01","end":"2020-03-31","val":105247,"accn":"0001493152-20-009028","fy":2020,"fp":"Q1","form":"10-Q","filed":"2020-05-15","frame":"CY2020Q1"}]}},"IncreaseDecreaseInAccruedLiabilities":{"label":"Increase (Decrease) in Accrued Liabilities","description":"The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":16408,"accn":"0001493152-20-009028","fy":2020,"fp":"Q1","form":"10-Q","filed":"2020-05-15","frame":"CY2020Q1"}]}},"IncreaseDecreaseInPrepaidExpense":{"label":"Increase (Decrease) in Prepaid Expense","description":"The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":3685,"accn":"0001493152-20-009028","fy":2020,"fp":"Q1","form":"10-Q","filed":"2020-05-15","frame":"CY2020Q1"}]}},"IntangibleAssetsNetExcludingGoodwill":{"label":"Intangible Assets, Net (Excluding Goodwill)","description":"Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.","units":{"USD":[{"end":"2019-12-31","val":434273,"accn":"0001493152-20-009028","fy":2020,"fp":"Q1","form":"10-Q","filed":"2020-05-15","frame":"CY2019Q4I"},{"end":"2020-03-31","val":426410,"accn":"0001493152-20-009028","fy":2020,"fp":"Q1","form":"10-Q","filed":"2020-05-15","frame":"CY2020Q1I"}]}},"LeaseAndRentalExpense":{"label":"Operating Leases, Rent Expense","description":"Amount of rent expense incurred for leased assets, including but not limited to, furniture and equipment, that is not directly or indirectly associated with the manufacture, sale or creation of a product or product line.","units":{"USD":[{"start":"2019-01-01","end":"2019-03-31","val":16626,"accn":"0001493152-20-009028","fy":2020,"fp":"Q1","form":"10-Q","filed":"2020-05-15","frame":"CY2019Q1"}]}},"LiabilitiesAndStockholdersEquity":{"label":"Liabilities and Equity","description":"Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.","units":{"USD":[{"end":"2019-12-31","val":698439,"accn":"0001493152-20-009028","fy":2020,"fp":"Q1","form":"10-Q","filed":"2020-05-15","frame":"CY2019Q4I"},{"end":"2020-03-31","val":461043,"accn":"0001493152-20-009028","fy":2020,"fp":"Q1","form":"10-Q","filed":"2020-05-15","frame":"CY2020Q1I"}]}},"LiabilitiesCurrent":{"label":"Liabilities, Current","description":"Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.","units":{"USD":[{"end":"2019-12-31","val":396482,"accn":"0001493152-20-009028","fy":2020,"fp":"Q1","form":"10-Q","filed":"2020-05-15","frame":"CY2019Q4I"},{"end":"2020-03-31","val":518137,"accn":"0001493152-20-009028","fy":2020,"fp":"Q1","form":"10-Q","filed":"2020-05-15","frame":"CY2020Q1I"}]}},"NetCashProvidedByUsedInFinancingActivities":{"label":"Net Cash Provided by (Used in) Financing Activities","description":"Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.","units":{"USD":[{"start":"2019-01-01","end":"2019-03-31","val":104500,"accn":"0001493152-20-009028","fy":2020,"fp":"Q1","form":"10-Q","filed":"2020-05-15","frame":"CY2019Q1"}]}},"NetCashProvidedByUsedInOperatingActivities":{"label":"Net Cash Provided by (Used in) Operating Activities","description":"Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.","units":{"USD":[{"start":"2019-01-01","end":"2019-03-31","val":-187738,"accn":"0001493152-20-009028","fy":2020,"fp":"Q1","form":"10-Q","filed":"2020-05-15","frame":"CY2019Q1"},{"start":"2020-01-01","end":"2020-03-31","val":-233218,"accn":"0001493152-20-009028","fy":2020,"fp":"Q1","form":"10-Q","filed":"2020-05-15","frame":"CY2020Q1"}]}},"NetCashProvidedByUsedInOperatingActivitiesContinuingOperations":{"label":"Net Cash Provided by (Used in) Operating Activities, Continuing Operations","description":"Amount of cash inflow (outflow) from operating activities, excluding discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.","units":{"USD":[{"start":"2019-01-01","end":"2019-03-31","val":-142358,"accn":"0001493152-20-009028","fy":2020,"fp":"Q1","form":"10-Q","filed":"2020-05-15","frame":"CY2019Q1"},{"start":"2020-01-01","end":"2020-03-31","val":-233218,"accn":"0001493152-20-009028","fy":2020,"fp":"Q1","form":"10-Q","filed":"2020-05-15","frame":"CY2020Q1"}]}},"NetIncomeLoss":{"label":"Net Income (Loss) Attributable to Parent","description":"The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.","units":{"USD":[{"start":"2019-01-01","end":"2019-03-31","val":-442657,"accn":"0001493152-20-009028","fy":2020,"fp":"Q1","form":"10-Q","filed":"2020-05-15","frame":"CY2019Q1"},{"start":"2020-01-01","end":"2020-03-31","val":-364459,"accn":"0001493152-20-009028","fy":2020,"fp":"Q1","form":"10-Q","filed":"2020-05-15","frame":"CY2020Q1"}]}},"NetIncomeLossAvailableToCommonStockholdersBasic":{"label":"Net Income (Loss) Available to Common Stockholders, Basic","description":"Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.","units":{"USD":[{"start":"2019-01-01","end":"2019-03-31","val":-603136,"accn":"0001493152-20-009028","fy":2020,"fp":"Q1","form":"10-Q","filed":"2020-05-15","frame":"CY2019Q1"},{"start":"2020-01-01","end":"2020-03-31","val":-364459,"accn":"0001493152-20-009028","fy":2020,"fp":"Q1","form":"10-Q","filed":"2020-05-15","frame":"CY2020Q1"}]}},"OperatingExpenses":{"label":"Operating Expenses","description":"Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.","units":{"USD":[{"start":"2019-01-01","end":"2019-03-31","val":163595,"accn":"0001493152-20-009028","fy":2020,"fp":"Q1","form":"10-Q","filed":"2020-05-15","frame":"CY2019Q1"},{"start":"2020-01-01","end":"2020-03-31","val":364459,"accn":"0001493152-20-009028","fy":2020,"fp":"Q1","form":"10-Q","filed":"2020-05-15","frame":"CY2020Q1"}]}},"PreferredStockParOrStatedValuePerShare":{"label":"Preferred Stock, Par or Stated Value Per Share","description":"Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.","units":{"USD":[{"end":"2017-09-13","val":0.001,"accn":"0001493152-20-009028","fy":2020,"fp":"Q1","form":"10-Q","filed":"2020-05-15","frame":"CY2017Q3I"},{"end":"2019-12-31","val":0.001,"accn":"0001493152-20-009028","fy":2020,"fp":"Q1","form":"10-Q","filed":"2020-05-15","frame":"CY2019Q4I"},{"end":"2020-03-31","val":0.001,"accn":"0001493152-20-009028","fy":2020,"fp":"Q1","form":"10-Q","filed":"2020-05-15","frame":"CY2020Q1I"}]}},"PreferredStockSharesAuthorized":{"label":"Preferred Stock, Shares Authorized","description":"The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.","units":{"shares":[{"end":"2017-09-13","val":20000000,"accn":"0001493152-20-009028","fy":2020,"fp":"Q1","form":"10-Q","filed":"2020-05-15","frame":"CY2017Q3I"},{"end":"2019-12-31","val":20000000,"accn":"0001493152-20-009028","fy":2020,"fp":"Q1","form":"10-Q","filed":"2020-05-15","frame":"CY2019Q4I"},{"end":"2020-03-31","val":20000000,"accn":"0001493152-20-009028","fy":2020,"fp":"Q1","form":"10-Q","filed":"2020-05-15","frame":"CY2020Q1I"}]}},"PrepaidExpenseNoncurrent":{"label":"Prepaid Expense, Noncurrent","description":"Sum of the carrying amounts as of the balance sheet date of amounts paid in advance for expenses which will be charged against earnings in periods after one year or beyond the operating cycle, if longer.","units":{"USD":[{"end":"2020-03-31","val":3685,"accn":"0001493152-20-009028","fy":2020,"fp":"Q1","form":"10-Q","filed":"2020-05-15","frame":"CY2020Q1I"}]}},"ProfessionalFees":{"label":"Professional Fees","description":"A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer.","units":{"USD":[{"start":"2019-01-01","end":"2019-03-31","val":17457,"accn":"0001493152-20-009028","fy":2020,"fp":"Q1","form":"10-Q","filed":"2020-05-15","frame":"CY2019Q1"},{"start":"2020-01-01","end":"2020-03-31","val":157248,"accn":"0001493152-20-009028","fy":2020,"fp":"Q1","form":"10-Q","filed":"2020-05-15","frame":"CY2020Q1"}]}},"ResearchAndDevelopmentExpense":{"label":"Research and Development Expense","description":"The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":94048,"accn":"0001493152-20-009028","fy":2020,"fp":"Q1","form":"10-Q","filed":"2020-05-15","frame":"CY2020Q1"}]}},"RetainedEarningsAccumulatedDeficit":{"label":"Retained Earnings (Accumulated Deficit)","description":"The cumulative amount of the reporting entity's undistributed earnings or deficit.","units":{"USD":[{"end":"2019-12-31","val":-13126910,"accn":"0001493152-20-009028","fy":2020,"fp":"Q1","form":"10-Q","filed":"2020-05-15","frame":"CY2019Q4I"},{"end":"2020-03-31","val":-13491369,"accn":"0001493152-20-009028","fy":2020,"fp":"Q1","form":"10-Q","filed":"2020-05-15","frame":"CY2020Q1I"}]}},"ShareBasedCompensation":{"label":"Share-based Payment Arrangement, Noncash Expense","description":"Amount of noncash expense for share-based payment arrangement.","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":5408,"accn":"0001493152-20-009028","fy":2020,"fp":"Q1","form":"10-Q","filed":"2020-05-15","frame":"CY2020Q1"}]}},"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber":{"label":"Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number","description":"The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.","units":{"shares":[{"end":"2020-03-31","val":2075000,"accn":"0001493152-20-009028","fy":2020,"fp":"Q1","form":"10-Q","filed":"2020-05-15","frame":"CY2020Q1I"}]}},"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice":{"label":"Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price","description":"The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.","units":{"USD":[{"end":"2020-03-31","val":0.63,"accn":"0001493152-20-009028","fy":2020,"fp":"Q1","form":"10-Q","filed":"2020-05-15","frame":"CY2020Q1I"}]}},"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber":{"label":"Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number","description":"Number of options outstanding, including both vested and non-vested options.","units":{"shares":[{"end":"2019-12-31","val":2450000,"accn":"0001493152-20-009028","fy":2020,"fp":"Q1","form":"10-Q","filed":"2020-05-15","frame":"CY2019Q4I"},{"end":"2020-03-31","val":2450000,"accn":"0001493152-20-009028","fy":2020,"fp":"Q1","form":"10-Q","filed":"2020-05-15","frame":"CY2020Q1I"}]}},"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice":{"label":"Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price","description":"Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.","units":{"USD":[{"end":"2019-12-31","val":0.57,"accn":"0001493152-20-009028","fy":2020,"fp":"Q1","form":"10-Q","filed":"2020-05-15","frame":"CY2019Q4I"},{"end":"2020-03-31","val":0.57,"accn":"0001493152-20-009028","fy":2020,"fp":"Q1","form":"10-Q","filed":"2020-05-15","frame":"CY2020Q1I"}]}},"StockholdersEquity":{"label":"Stockholders' Equity Attributable to Parent","description":"Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.","units":{"USD":[{"end":"2018-12-31","val":-253673,"accn":"0001493152-20-009028","fy":2020,"fp":"Q1","form":"10-Q","filed":"2020-05-15","frame":"CY2018Q4I"},{"end":"2019-03-31","val":-696330,"accn":"0001493152-20-009028","fy":2020,"fp":"Q1","form":"10-Q","filed":"2020-05-15","frame":"CY2019Q1I"},{"end":"2019-12-31","val":301957,"accn":"0001493152-20-009028","fy":2020,"fp":"Q1","form":"10-Q","filed":"2020-05-15","frame":"CY2019Q4I"},{"end":"2020-03-31","val":-57094,"accn":"0001493152-20-009028","fy":2020,"fp":"Q1","form":"10-Q","filed":"2020-05-15","frame":"CY2020Q1I"}]}},"WeightedAverageNumberOfShareOutstandingBasicAndDiluted":{"label":"Weighted Average Number of Shares Outstanding, Basic and Diluted","description":"Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).","units":{"shares":[{"start":"2019-01-01","end":"2019-03-31","val":9650133,"accn":"0001493152-20-009028","fy":2020,"fp":"Q1","form":"10-Q","filed":"2020-05-15","frame":"CY2019Q1"},{"start":"2020-01-01","end":"2020-03-31","val":17483283,"accn":"0001493152-20-009028","fy":2020,"fp":"Q1","form":"10-Q","filed":"2020-05-15","frame":"CY2020Q1"}]}}}}}